During the past decade, Miejski Szpital Zespolony w Olsztynie conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miejski Szpital Zespolony w Olsztynie" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Miejski Szpital Zespolony w Olsztynie" are "Psoriasis" (2 trials), "Atopic Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Miejski Szpital Zespolony w Olsztynie" in a lesser frequency.

Most popular intervention types in "Miejski Szpital Zespolony w Olsztynie" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "BMS-986165" (2 trials), "Apremilast" (1 trials), "Baricitinib" (1 trials) and "CC-93538" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miejski Szpital Zespolony w Olsztynie" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Miejski Szpital Zespolony w Olsztynie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Miejski Szpital Zespolony w Olsztynie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miejski Szpital Zespolony w Olsztynie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".